DEC orders changes at Great Lakes Cheese after Ischua Creek fish kill
Breaking News
DEC orders changes at Great Lakes Cheese after Ischua Creek fish kill
By BOB CLARK bclark@oleantimesherald.com 
August 29, 2025
FRANKLINVILLE — State environmental officers said immediate changes are needed after a fish kill in Ischua Creek was triggered by pollution from the G...
Home Online Features Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren's disease study
Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study
Hand-out
Press Releases
Johnson & Johnson  
November 14, 2024

Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study

Adults with moderately-to-severely active Sjögren's disease who received investigational FcRn blocker nipocalimab had improvements in disease activity scores at 24 weeks with accompanying significant reductions in IgG and autoantibody levels

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social